Potential of longitudinal data from single site and multi-center clinical trials for AI-research

Prof. Dr. Hans-Christoph Becker from Stanford University, a long-standing user of mint Lesion™, shares his experience of using the software in this brief interview. He talks about the reaction he received when sharing the mint report for the first time, how patients benefit from the longitudinal overview of disease, and his plans to use the structured data for AI research.

Click here or on the image above to watch the full video on YouTube.

Structured Reporting Clinical Trials Clinical Research Standardized Reading Procedures Multi-site Clinical Trials AI Video

Related Resources

Related Resources

PET scans of torso with relevant false positives highlighted by red dotted circles, true positives in green

LMU University Hospital: Artificial Intelligence for TNM Staging in NSCLC – How Reliable Are AI-Based Segmentations?

The recent study “Artificial intelligence for TNM staging in NSCLC – a critical appraisal of segmentation utility in [¹⁸F]FDG PET/CT” provides a…

Participants at the RECIST and Beyond workshop in Cologne during hands-on training with mint Lesion for structured tumor response assessment.

Successful “RECIST and Beyond” Workshop in Cologne: Advancing Precision in Oncologic Imaging

How can complex tumor findings be assessed accurately, reproducibly, and in line with clinical guidelines?

Screenshot of the mint Lesion interface showing RANO 2.0 configuration, tumor burden calculations, and structured neuro-oncology assessment tools.

Implementing RANO 2.0 for Neuro-Oncology Clinical Trials in mint Lesion

Tumor response assessment in neuro-oncology clinical trials requires careful attention to measurement protocols and confirmation scan requirements. To…